Structure (Image 01)
Not available.*
Tembexa
Product Images NDC 79622-010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 79622-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chimerix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Blister Carton Label)
TEMBEXA is a medication that comes in the form of tablets and can be taken orally. The tablets contain 100 mg of brincidofovir and the recommended dose is two tablets, totaling 200 mg, to be taken once a week for two weeks. The tablets should not be split, broken, or crushed. TEMBEXA is intended for patients weighing 48 kg (106 lbs) or above and can be taken with or without food. The wallet packaging is child-resistant, and the blister card should be kept out of the reach of children. The medication should be stored at a temperature ranging from 20°C to 25°C (68°F to 77°F), and excursions are allowed from 15°C to 30°C (69°F to 86°F). For more information on TEMBEXA, refer to the full prescribing information provided inside the package.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
